SAM
CYTO

Sectoral Asset Management’s Altamira Therapeutics Ltd CYTO Stock Holding History

Sectoral Asset Management’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3
Closed -$1.11M – 91
2015
Q2 		$1.11M Hold
3
– – 0.05% 69
2015
Q1 		$1.5M Buy
+3
New +$1.21M 0.06% 65

Other funds holding CYTO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BAMS
Bellevue Asset Management (Switzerland) Kuesnacht, Switzerland $656M AUM 11.45% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return

Sectoral Asset Management's CYTO Position: Q3 2015 in Review

Sectoral Asset Management sold out of Altamira Therapeutics Ltd (CYTO) in Q3 2015, closing a stake of 3 shares — an estimated $1.11M sold.

Sectoral Asset Management first reported a position in CYTO in Q1 2015 and held it in 2 quarters. The position peaked at $1.5M in Q1 2015. 10 funds tracked by Wall St. Rank hold CYTO as of Q3 2015.

  • Sectoral Asset Management reported no remaining Altamira Therapeutics Ltd position as of Q3 2015 after selling out during the quarter.
  • Sectoral Asset Management sold 3 Altamira Therapeutics Ltd shares in Q3 2015, an estimated $1.11M.
  • Sectoral Asset Management first reported a position in Altamira Therapeutics Ltd in Q1 2015 and held it in 2 quarters.
  • Sectoral Asset Management's Altamira Therapeutics Ltd position peaked at $1.5M in Q1 2015.
  • 10 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q3 2015.

Based on Sectoral Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.